There are several high visibility papers on lack of reproducibility in drug development by Pharma, so I don't think there is a particular bias in less reproducible research. Indeed, since life sciences research in academia is almost all funded by the NIH, with grant reviews/renewals every 3-5 years, there is probably more scrutiny of academic research than commercial.